Figure 4. ATXN3 localizes to non-acidified regenerating lysosomes.
(A) 3D-SIM live-cell imaging of stable HeLa LAMP1-BFP cells loaded with lysotracker and expressing ATXN3-GFP. Cells were treated with 1 mM LLOMe for 12 min, washed, and followed during recovery in medium containing lysotracker for 3 h. Scale bar, 5 µm. (B) Quantification of 2D-SIM images taken in experiments shown in (A). n = 2 biologically independent experiments with >20 cells quantified per experiment. Lines indicate the median. (C) HeLa cells expressing ATXN3-mCherry and the PI(4,5)P2 sensor GFP-PH (PLCD1) were mock or LLOMe-treated as indicated and immuno-stained for LAMP1. Note the colocalization of ATXN3 and GFP-PH on a subpopulation of lysosomes. Scale bar, 10 µm. (D) Quantification of (C), n = 3 biological replicates with >20 cells per condition per experiment. One-way ANOVA with Tukey’s multiple comparison test. The line indicates the mean. (E) DQ-BSA assay for proteolytic activity in lysosomes. HeLa parental and ATXN3 knockout cells were LLOMe-treated for 1 h. DQ-BSA was added 13 h after washout, and DQ-BSA fluorescence in lysosomes was imaged at a total of 20 h after LLOMe washout. Scale bar, 10 µm. (F) Quantification of (E), n = 3 biological replicates with >40 cells per condition per experiment. Mixed effects analysis with Tukey’s multiple comparison test. Error bars represent the mean with SD. Source data are available online for this figure.
